The International Institute for Human Development (IIHD) India jointly with Coalition for Global Hepatitis Elimination and eHealth is organizing a 1st Asia Pacific Hepatitis Summit (Virtual) on
World Hepatitis Day, 28 July.
Theme of the Summit: How to find Missing Millions?
Message for the audience of 1st Asia Pacific Virtual Hepatitis Summit on World Hepatitis Day, 28 July 2020. This Summit was organized by the International Institute for Human Development in collaboration with partners.
an Indian Gastroenterologist, Hepatologist, a pioneer in clinical innovations. former chairman of the Board of Governors of the Medical Council of India. He is Director, Institute of Liver and Biliary Sciences and Founder of Asian Pacific Association for study of Liver.
Director, Coalition for Global Hepatitis Elimination, The Task Force for Global Health Inc. Atlanta
Organizing Secretary, Summit
Director, Patient Access & Social Impact, IIHD India
Chair, Diagnostics Research, LSHTM & Director, International Diagnostics Centre, London
Former DDG, Government of India
& Advisor, IIHD
Professor of Medicine,
National Liver Institute, Egypt
Senior Gastroenterologist, Indian National Association for the Study of the Liver
A Padma Shri Awardee, a gastroenterologist and liver transplant physician
Senior Gastroenterologist & Hepatologist; and President, Indian Society of Gastroenterology (UP)
Director – Immunization Technical Support Unit, John Snow India
State Program Manager, Ministry of Health and Family Welfare, Government of Punjab
Professor & Head, Department of Hepatology, Institute of PGMER & Research, Kolkata
Founder, Kalinga Liver Foundation and Gastroenterologist
Founder of Chennai Liver Foundation; Professor & Head, Dept of Surgical Gastroenterology at SMC, Chennai
Roche Diagnostics, India
Researcher, Massachusetts General Hospital, Boston, USA
Center of Excellence in Clinical Virology, Department of Pediatrics,
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Global deaths from viral hepatitis continue to rise, and more than 60% occur in the Asia Pacific region. Hepatitis B and C are chronic infections that may not show symptoms for a long period, sometimes years or decades. At least 60% of liver cancer cases are due to late testing and treatment of viral hepatitis B and C. Low coverage of testing and treatment is the most important gap to be addressed in order to achieve the global elimination goals by 2030.
There have been calls from public health experts to include viral hepatitis as one of the main targets for public health efforts – along with the ‘big three’ (malaria, TB and HIV/AIDS). While deaths from these ‘big three’ infectious diseases have gradually decreased over time, those from viral hepatitis continue to increase. And yet transmission is preventable, hepatitis B is treatable and hepatitis C is now curable with existing treatments.
Though almost all the individual countries in the region have been implementing preventive strategies for viral hepatitis-related liver disease include increasing access to clean drinking water and sanitation, HBV vaccination programmes for neonates, however, availability of screening tests for blood and tissue, donor recall policies, and harm reduction strategies are in their initial stages in most countries. Furthermore, many governments have put HBV and HCV drugs on their essential medicines lists and the availability of generic versions of these drugs has reduced costs.
Despite some promising examples of good practice from individual countries, more needs to be done. National governments, international and local community and diagnostic and pharmaceutical industries must recognise the urgency of this issue and collaborate to translate strategic plans into concrete action. There must be a renewed focus on prevention, early detection and timely referral to improve health interventions to reduce the burden of liver diseases in the Asia-Pacific region.
On 28 July every year, the World Hepatitis Day (WHD) takes places bringing the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2020 the theme is ‘Find the Missing Millions’. Without finding the undiagnosed and linking them to care, millions will continue to suffer, and lives will be lost. On World Hepatitis Day, 28 July, IIHD India jointly with partners is organizing a 1st Asia Pacific Hepatitis Summit (virtual) inviting people from across the world, particularly resource constrained countries, including India - to discuss strategies and approaches to find the “missing millions”.
This invitation-only event is a virtual gathering of “thoughtful, iconoclastic doers” who share a common interest in practical solutions to address the issue. We expect several hundred people from emerging markets to participate, including policymakers, leading companies, entrepreneurs, NGOs, academic institutions, scientists/researchers, and other stakeholders.
We will focus exclusively on one of the most important practical challenge of addressing the public health issue of Viral Hepatitis, i.e. How to find missing millions?
11.00 AM - 12 NOON (IST):
Session 1: What are the programmatic lessons learned and technological innovations that can advance delivery of hepatitis B & C testing in Asia Pacific countries and globally ?
12.15 PM - 01.15 PM (IST)
Session 2: What strategies and public-private partnerships help governments address access and affordability issues of hepatitis testing?
03.00 PM - 04.00 PM (IST)
Session 3: How Civil Society and the Affected Community should be engaged in overcoming barriers to find the Missing Millions?